Compare PUBM & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PUBM | MLAB |
|---|---|---|
| Founded | 2006 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 406.5M | 441.2M |
| IPO Year | 2020 | N/A |
| Metric | PUBM | MLAB |
|---|---|---|
| Price | $9.21 | $77.50 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 1 |
| Target Price | $18.45 | ★ $67.00 |
| AVG Volume (30 Days) | ★ 1.1M | 186.1K |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 0.82% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $288,382,000.00 | $245,255,000.00 |
| Revenue This Year | N/A | $4.96 |
| Revenue Next Year | $0.49 | $5.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.39 |
| 52 Week Low | $7.01 | $55.45 |
| 52 Week High | $17.32 | $155.12 |
| Indicator | PUBM | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 54.40 | 53.91 |
| Support Level | $8.91 | $70.19 |
| Resistance Level | $9.24 | $82.87 |
| Average True Range (ATR) | 0.35 | 3.86 |
| MACD | -0.00 | 0.07 |
| Stochastic Oscillator | 61.62 | 60.82 |
PubMatic Inc is a supply-side platform provider in the digital advertising technology market. These platforms help publishers, which supply digital ad inventory, manage their inventory, selling a high percentage of their inventory (increase the ad fill rate) and maximizing revenue per ad sold (optimize yield). The company generates revenue mainly by taking a piece of the ad sales that it enables. Buyers on the platform include intermediary buyers, such as demand-side platforms, or advertisers and ad agencies directly. Geographically, the company generates the majority of its revenue from the United States, followed by EMEA and APAC.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.